Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 53-63, January 2010

Albumin Usage in Clinical Medicine: Tradition or Therapeutic?

  • Albert Farrugia

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Albert Farrugia, Plasma Protein Therapeutics Association, 147 Old Solomon's Island Rd. Annapolis, MD 21401.

Plasma Protein Therapeutics Association, Annapolis, MD

Centre for Orthopaedic Research/Department of Surgery, Faculty of Medicine and Surgery, University of Western Australia, WA, Australia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: The author provides contractual services for the Plasma Protein Therapeutics Association, which represents the manufacturers of plasma products, including albumin, which operate on a profit basis.

PII: S0887-7963(09)00085-6

doi:10.1016/j.tmrv.2009.09.005

Transfusion Medicine Reviews
Volume 24, Issue 1 , Pages 53-63, January 2010

Article Tools

* Image Usage & Resolution